Fact CheckerSign in

NCT05469360Active, not recruitingPhase 1

Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants

Source: EU CTIS (euclinicaltrials.eu) · Last updated 4 Sept 2026

Status (registry)
Active, not recruiting
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
37 (estimated)
First submitted
12 Jul 2024
Start date
23 Feb 2023
Lead sponsor
Novartis Pharma AG
NCT number
NCT05469360
EU CT number
2024-514004-14-00
EudraCT number
2022-000921-26

What you commit to

  • Study type: Interventional · Phase 1
  • Planned participants: 37
  • 10 sites in 4 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Sites (10)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital Clinic de Barcelona
Coordinator of this site? Confirm its status
BarcelonaSpainActive, not recruiting
Hospital de la Santa Creu i Sant Pau
Coordinator of this site? Confirm its status
BarcelonaSpainActive, not recruiting
Hospital Universitario Dr. Peset Aleixandre
Coordinator of this site? Confirm its status
ValenciaSpainActive, not recruiting
University Of Eastern Finland
Coordinator of this site? Confirm its status
KuopioFinlandCompleted
Clinical Research Services Turku -CRST Oy
Coordinator of this site? Confirm its status
TurkuFinlandCompleted
Centre Hospitalier Universitaire De Lille
Coordinator of this site? Confirm its status
Lille CedexFranceActive, not recruiting
Assistance Publique Hopitaux De Paris
Coordinator of this site? Confirm its status
Paris Cedex 13FranceActive, not recruiting
Centre Hospitalier Universitaire de Toulouse
Coordinator of this site? Confirm its status
ToulouseFranceActive, not recruiting
Karolinska University Hospital
Coordinator of this site? Confirm its status
HuddingeSwedenCompleted
Region Skane Skanes Universitetssjukhus
Coordinator of this site? Confirm its status
MalmoSwedenCompleted

This page is information, not medical advice. Discuss any trial with your doctor.